8-KThe WireRoutine
Bylaw Amendment
Filed Oct 30, 2020 · 5y ago · Accession 0000886163-20-000116
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- LIGAND PHARMACEUTICALS INC
- Ticker
- LGND
- CIK
- 886163
- Form type
- 8-K
- Filing date
- Oct 30, 2020
- Report date
- Oct 26, 2020
- Document
- lgnd-20201026.htm
- Size
- 374 KB